20 participants
Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2026-09-07
- Completion:
- 2030-07-07
Conditions
- Lung Cancer (NSCLC)
- HER2 Expression
- HER2 Gene Mutation
Interventions
- DIAGNOSTIC_TEST
No Results Yet